NSC |
Compound |
Enrichment |
Correlation |
NSC 671139 |
Null |
0.0065871594677386 |
0.11495433 |
NSC 683664 |
2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[3-(dimethylamino)- 1-oxopropoxy)-19-[(2-propenyl)amino]-,stere |
0.0065871594677386 |
0.18415459 |
NSC 689227 |
3-Hydroxy-4-[4-[3-(4-isopropylcyclohexanony)butyl]]cyclo pentanone tert-butyldimethylsilyl ether |
0.0065871594677386 |
0.2299748 |
NSC 698395 |
Morpholine, 4,4'-(3,4-dichloro-2,4-dinitro-1,3-butadiene- 1,1-diyl)bis-, (1E,3E)- |
0.0065871594677386 |
0.21298783 |
NSC 702415 |
Null |
0.0065871594677386 |
0.15111038 |
NSC 742295 |
(11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one |
0.0065871594677386 |
0.086547038 |
NSC 665534 |
5-Quinolinesulfonic acid, 7,7'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)iminocarbonyl]]bis[8-hydroxy-, tetrasodium salt |
0.0070787592519192 |
0.25018757 |
NSC 671135 |
Null |
0.0070787592519192 |
0.0019360449 |
NSC 679095 |
Null |
0.0070787592519192 |
-0.17724081 |
NSC 691895 |
Null |
0.0070787592519192 |
0.42142069 |